Why the study?
Sympathetic dysregulation is supposed to be the underlying mechanism of increased cardiovascular risk in anorexia nervosa, prompting the evaluation of electrodermal activity as a potential biomarker.
Does electrodermal activity analysis identify sympathetic cholinergic dysregulation in adolescent girls with anorexia nervosa compared to healthy controls?
Does electrodermal activity analysis identify sympathetic cholinergic dysregulation in adolescent girls with anorexia nervosa compared to healthy controls?
Complex electrodermal activity analysis, particularly the nonlinear index DFA, may serve as a sensitive biomarker for sympathetic cholinergic dysregulation and associated cardiovascular risk in adolescent anorexia nervosa.
EDA analysis may flag sympathetic dysregulation in adolescent AN; hypothesis-generating and should not yet change practice.
Anorexia nervosa (AN) is an eating disorder with increasing prevalence in childhood and adolescence. Sympathetic dysregulation is supposed to be the underlying mechanism of increased cardiovascular risk in AN. Thus, we assess the electrodermal activity (EDA) as a non-invasive index of sympathetic cholinergic activity using linear and nonlinear analysis in adolescent AN with the aim of detecting potential biomarkers for AN-linked cardiovascular risk. We examined 25 adolescent girls with AN and 25 age-matched controls. EDA was continuously recorded during a 5-min resting phase. Evaluated parameters were: time-domain (skin conductance level, non-specific skin conductance responses), frequency-domain (EDA in very low, low, sympathetic, high and very high frequency bands) and nonlinear (approximate, sample, symbolic information entropies, detrended fluctuation analysis (DFA)) parameters of EDA and peripheral skin temperature. Our findings revealed lower EDA values indicating a decrease in the sympathetic nervous activity in female adolescents with the acute phase of AN. Further, we found higher nonlinear index DFA in AN vs. controls. We assumed that nonlinear index DFA could provide novel and independent information on the complex sympathetic regulatory network. We conclude that the parameters of complex EDA analysis could be used as sensitive biomarkers for the assessment of sympathetic cholinergic dysregulation as a risk factor for AN-linked cardiovascular morbidity.
No takes yet. Share an insight, caveat, or question.
Višňovcová et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: